The Impact of MACA Supplementation on Basketball-related Performance

February 1, 2024 updated by: Chih-Hui Chiu, National Taiwan Sport University

The Impact of Lepidium Meyenii (MACA) Supplementation on Basketball-related Performance and Anti-fatigue Ability: a Double Blind Crossover Study

In this randomized crossover study, ten elite healthy male basketball players were included. Following a 17:00 PM training routine, participants completed a two-week supplementation with 2000 mg of MACA or placebo. After supplementation, participants underwent a Basketball Jump Shooting Accuracy Test and Repeated Sprint Ability Test.

Study Overview

Status

Completed

Conditions

Detailed Description

Supplementation with Lepidium meyenii (MACA) has been shown in animal studies to increase blood lactate clearance and rapid lactate removal, which may be effective in reducing fatigue during intermittent exercise. However, no studies have investigated the effects of MACA supplementation on interval exercise and basketball performance. We hypothesized that MACA supplementation could reduce fatigue and improve performance in elite healthy male basketball players. This study aimed to determine the effectiveness of MACA compared to placebo on overall basketball performance.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taichung, Taiwan, 404
        • National Taiwan University of Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • (i) healthy male adults, those individuals who are free of pain, insomnia, or other injuries recently, without any medication used in recent 2 months,
  • (ii) basketball players competing in a Taiwan university basketball association for more than two years.

Exclusion Criteria:

  • (i) were below 20 years old,
  • (ii) did not have won at least eighth place in national-level basketball competitions,
  • (iii) were with cardiovascular diseases or any disease that made subjects feel ill.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MACA (MC)
Daily MACA supplementation for two weeks.
The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.
Other Names:
  • 100% corn-starch maltodextrin powder
Placebo Comparator: placebo
Daily placebo supplementation for two weeks.
The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.
Other Names:
  • 100% corn-starch maltodextrin powder

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement jump test
Time Frame: immediately after 2 weeks intervention
Three jumps were measured with 1 minute rest for each participant.
immediately after 2 weeks intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Basketball Jump Shooting Accuracy Test
Time Frame: immediately after 2 weeks intervention
The first test was the basketball jump shooting Accuracy Test (BJSAT), which has been used in the past with sufficient reliability to two and three-point shooting accuracy
immediately after 2 weeks intervention
Repeated Sprint Ability Test
Time Frame: immediately after 2 weeks intervention
Repeated Sprint Ability test (40× 15m with a 1:4, exercise : rest time ratio, such as 2 seconds :8 seconds)
immediately after 2 weeks intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Che-Hsiu Chen, PhD, Sport Science Research Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

January 14, 2024

First Submitted That Met QC Criteria

February 1, 2024

First Posted (Actual)

February 6, 2024

Study Record Updates

Last Update Posted (Actual)

February 6, 2024

Last Update Submitted That Met QC Criteria

February 1, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No personal data of participants will be provided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports

Clinical Trials on Lepidium meyenii (MACA)

Subscribe